GLP-1 Weight Loss in Lexington, KY: Below Kentucky's Obesity Rate, Still Behind on Price Transparency
Lexington-Fayette's obesity rate against Kentucky's, MedImpact's diabetes-only Medicaid rule, one published local price out of three clinics, and UK HealthCare's regional referral load.
Lexington-Fayette's crude adult obesity rate is 33.9% (CDC PLACES 2024 release, sd8v-uq83, BRFSS 2022) 1 against Kentucky's 37.7% statewide rate for the same survey year (CDC BRFSS) 3, a gap of roughly 3.8 points. Kentucky is absent from the OBESITY measure in the newer PLACES 2025 release 2, which is why the 2024 release is the source here.
Lexington and Fayette County are coterminous under the Lexington-Fayette Urban County Government: 329,437 residents inside a 533,366-person metro, with a median household income of $69,989 and 4.9% uninsured 4567.
County
Fayette County — consolidated as the Lexington-Fayette Urban County Government (city and county are coterminous)
Fayette County carries no active, county-wide primary care HPSA designation — a broad 'Low Income – North Central Lexington' geographic designation existed in HRSA's records but was withdrawn on 08/25/1980 and never reinstated. Current designations are all facility-specific: Health First Bluegrass FQHC (HPSA score 22, designation population 74,197), Bluegrass Primary Health Care Center FQHC (score 21, population 82,200), and the University of Kentucky FQHC (score 21, population 45,688), plus the federal prison FMC-Lexington (score 12, population 1,466). In short, Lexington as a whole is not classified as medically underserved for primary care — the shortage designation is concentrated in specific safety-net clinics serving low-income and incarcerated populations, not the general population.8
Specialist access
Lexington's specialist backbone is UK HealthCare, the University of Kentucky's academic medical center, which serves as the referral hub for a much larger, higher-need catchment across rural and Appalachian central and eastern Kentucky — a region with far more HPSA-designated counties than Fayette itself. No public dataset quantifies endocrinologist or obesity-medicine-specialist counts, appointment wait times, or referral patterns specific to Lexington, so that piece of the access picture is a genuine data gap rather than a number to guess at. What is measurable locally is price transparency: of three Lexington providers checked for published GLP-1 pricing, only one posts a number.8
Medicaid coverage note
Kentucky Medicaid's pharmacy benefit runs through a single contracted PBM, MedImpact. Its Preferred Drug List and Prior Authorization Criteria (version dated August 2026) require an ICD-10 Type 2 diabetes diagnosis plus A1c lab documentation (6.5% or higher, or a historical equivalent) for every covered GLP-1 receptor agonist — Mounjaro, Ozempic (pen and tablet), Trulicity, Victoza, Rybelsus, exenatide, liraglutide, Soliqua, and Xultophy. Each drug's criteria entry ends with the same line: 'Drugs used for anorexia, weight loss, or weight gain are excluded from coverage.' Wegovy, Zepbound, and Saxenda — the three GLP-1s actually indicated for obesity — do not appear anywhere in the 34-page PDL or the 289-page PA criteria document. Kentucky Medicaid, in other words, covers GLP-1s for diagnosed type 2 diabetes only; there is no state-Medicaid pathway to these drugs for weight loss alone.1213
Kentucky Medicaid covers GLP-1s for diabetes only
Kentucky Medicaid's pharmacy benefit runs through a single contracted PBM, MedImpact. Its Preferred Drug List and Prior Authorization Criteria (version dated August 2026) require an ICD-10 Type 2 diabetes diagnosis plus A1c lab documentation (6.5% or higher, or a historical equivalent) for every covered GLP-1 receptor agonist, Mounjaro, Ozempic (pen and tablet), Trulicity, Victoza, Rybelsus, exenatide, liraglutide, Soliqua, and Xultophy 1213.
Each drug's criteria entry ends with the same line: "Drugs used for anorexia, weight loss, or weight gain are excluded from coverage." Wegovy, Zepbound, and Saxenda, the three GLP-1s actually indicated for obesity, do not appear anywhere in the 34-page PDL or the 289-page PA criteria document 1213. Kentucky Medicaid, in other words, covers GLP-1s for diagnosed type 2 diabetes only; there is no state-Medicaid pathway to these drugs for weight loss alone.
What GLP-1 care costs in Lexington today
Of three Lexington providers checked, exactly one posts a number. Medi-Weightloss at 2909 Richmond Road, Suite 40 publishes GLP-1 pricing on its Lexington clinic page: compounded semaglutide at $99 for the first month and compounded tirzepatide at $199 for the first month, both stepping up to a $199/month membership after that, plus a separate $199 one-time new-patient visit fee, on 1-, 3-, or 6-month plans. Brand-name Wegovy and Zepbound are offered where insurance covers them. Checked 2026-08-28 9.
Rewind Medical, at 4384 Clearwater Way, Suite 190, runs GLP-1-assisted weight loss under its "Be Thin" program and publishes no price anywhere: the homepage, the dedicated weight-loss page, and the specials page all route to a phone call or a booked consultation instead of a number 10. Lexington Clinic, the city's largest multi-specialty physician group, lists a general Endocrinology service page with no weight-management or GLP-1 program at all, and no mention of semaglutide, tirzepatide, Wegovy, Ozempic, Zepbound, or Mounjaro 11.
Astra's national price is $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, $816 and $1,416 billed annually. That is the same everywhere Astra operates; it is not a Lexington rate.
UK HealthCare carries the region, and Fayette isn't the underserved part
Fayette County carries no active, county-wide primary care HPSA designation. A broad "Low Income - North Central Lexington" geographic designation existed in HRSA's records but was withdrawn on 08/25/1980 and never reinstated. The current designations are all facility-specific: Health First Bluegrass FQHC (score 22, designation population 74,197), Bluegrass Primary Health Care Center FQHC (score 21, population 82,200), the University of Kentucky FQHC (score 21, population 45,688), and the federal prison FMC-Lexington (score 12, population 1,466) 8. Lexington as a whole is not classified as medically underserved for primary care; the shortage sits in specific safety-net clinics serving low-income and incarcerated populations.
Lexington's specialist backbone is UK HealthCare, the University of Kentucky's academic medical center, which serves as the referral hub for a much larger, higher-need catchment across rural and Appalachian central and eastern Kentucky, a region with far more HPSA-designated counties than Fayette itself. No public dataset quantifies endocrinologist or obesity-medicine-specialist counts, appointment wait times, or referral patterns specific to Lexington, so that piece of the access picture is a genuine data gap rather than a number to guess at 8.
What is measurable locally is price transparency, and only one of three checked providers passes. Telehealth answers both problems at once: a licensed prescriber without the referral queue, at a price published before the visit. See the Kentucky GLP-1 overview for statewide context.
Astra treats patients in Kentucky through state-licensed physicians.
Local options
Medi-Weightloss (Lexington) — Publishes GLP-1 pricing directly on its Lexington clinic page: compounded semaglutide at $99 for the first month, compounded tirzepatide at $199 for the first month, both stepping up to a $199/month membership after that, plus a separate $199 one-time new-patient visit fee; plans run 1, 3, or 6 months. Brand-name Wegovy/Zepbound are offered where insurance covers them. Address: 2909 Richmond Road, Suite 40, Lexington, KY 40509 (859-269-2639). https://mediweightloss.com/weight-loss-clinic/lexington/(checked 2026-08-28)
Rewind Medical (Rewind Aesthetics, Dermatology and Trichology) — Local medspa at 4384 Clearwater Way, Suite 190, Lexington, KY 40515 (859-800-4771) offering GLP-1-assisted weight loss under its 'Be Thin' program. Publishes no price anywhere on its site — the homepage, its dedicated weight-loss page, and its specials page all route to a phone call or booked consultation instead of a number. https://rewind-medical.com/direct-primary-care/weightloss/bethin/(checked 2026-08-28)
Lexington Clinic — Lexington's largest multi-specialty physician group. Its site lists a general Endocrinology service page with no dedicated weight-management or GLP-1 program, and the page makes zero mention of semaglutide, tirzepatide, Wegovy, Ozempic, Zepbound, or Mounjaro. Ruled out as a GLP-1 pricing source. https://lexingtonclinic.com/services/endocrinology(checked 2026-08-28)
Frequently asked questions
What does GLP-1 weight-loss treatment cost in Lexington, KY today?
Only one of three Lexington providers checked publishes a price. Medi-Weightloss's Lexington clinic lists compounded semaglutide at $99 for the first month and compounded tirzepatide at $199 for the first month, both stepping up to a $199/month membership plus a separate $199 one-time new-patient visit fee. Rewind Medical offers GLP-1 care locally but discloses no price anywhere on its site, and Lexington Clinic, the city's largest physician group, has no visible GLP-1 or weight-management program at all.
Is Astra cheaper than local Lexington clinics for semaglutide or tirzepatide?
Astra's national price — $68/month for semaglutide, $118/month for tirzepatide, on 12-month plans — is the same in Lexington as everywhere else Astra operates. Against Medi-Weightloss, the one Lexington provider that publishes a price, Astra is lower on every line: $68/month beats Medi-Weightloss's own discounted $99 first-month semaglutide rate, and $118/month beats both its $199 first-month tirzepatide rate and its $199/month ongoing membership fee (which sits on top of a separate $199 one-time visit charge). Rewind Medical and Lexington Clinic don't publish a comparable number to check against at all.
How does Lexington's obesity rate compare to the rest of Kentucky?
Lexington-Fayette's crude adult obesity rate is 33.9% (CDC PLACES 2024 release, BRFSS 2022 data), about 3.8 percentage points below Kentucky's statewide adult obesity rate for the same survey year, 37.7% (CDC BRFSS). Kentucky remains one of the highest-obesity states in the country, but Lexington itself sits notably below the state average.
Does Kentucky Medicaid cover GLP-1 medications like Wegovy or Zepbound for weight loss?
No. Kentucky Medicaid's Preferred Drug List and Prior Authorization Criteria, administered by its pharmacy benefit manager MedImpact, require a Type 2 diabetes diagnosis and A1c documentation for every covered GLP-1 and explicitly exclude drugs 'used for anorexia, weight loss, or weight gain.' Wegovy, Zepbound, and Saxenda do not appear in either document, so there is no state-Medicaid path to these drugs for weight loss alone.
Is Lexington, KY a health professional shortage area, and does Astra serve it?
Fayette County is not classified as a general-population primary care shortage area — HRSA's current designations there apply only to three specific FQHC safety-net clinics, not the city as a whole. Regardless of local HPSA status, Astra is licensed in all 50 states, including Kentucky, so Lexington residents can start care today at the same $68/month semaglutide and $118/month tirzepatide pricing used everywhere else.